RMI2 and neoplasm: A recent study showed that RMI2 was significantly correlated with tumor mutation burden, microsatellite instability, immune cell infiltration, immune checkpoints, and mismatch repair‐related genes47 which suggests that RMI2 may influence the response to immunotherapy.